PRJNA473577
Toca 511 Sequencing from DNA isolated from Patient Samples
We sequenced Toca 511 genomes from phase 1 patients samples from tumor and blood. Toca 511 sequence profiles suggest most mutations are caused by APOBEC cytidine deaminases acting during reverse transcription.